HCM II Acquisition Corp announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “HONDU”, Friday, August 16, 2024.
The new SPAC intends to combine with an established company of scale in a competitive position within a defensible business niche.
HCM II’s sponsor team is to be led by Chairman and Chief Executive Officer Shawn Matthews alongside Chief Financial Officer Steven Bischoff. Andrew Brenner, Michael J. Connor and Jacob Loveless are to serve on the SPAC’s Board of Directors.
Total SPAC deal count for 2024 year-to-date is now 26. This offering is expected to close on Monday, August 19, 2024.
Cantor Fitzgerald & Co. is acting as sole book-running manager for the offering. King & Spalding LLP is serving as Issuer’s Counsel with Ellenoff Grossman & Schole LLP serving as Underwriter’s Counsel. Withum Smith+Brown, PC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.
At the SPAC of Dawn It has clearly taken some time for SPACs to break out from their niche, but SPACs and de-SPACs are suddenly everywhere in current events. As the Russian invasion of Ukraine drags on, one of the most prolific SPAC teams has stepped forward with a letter of intent to take Ukraine’s...
Live Oak Acquisition Corp. V (NASDAQ:LOKVU) has filed for a $200 million IPO that brings another serial SPAC team back to the mix for a generalist search but with a pair of technology deals already in their pocket. The new S-1 also puts Santander on the board for the 2025 SPAC market after it made...
CH4 Natural Solutions (NYSE:MTNE.U) has filed for a $250 million SPAC to bring both the Riverstone sponsor team and underwriter Citigroup back to the market for 2025. The team secured notably sponsor-friendly terms for the vehicle and will not overfund its trust. In fact, along with fellow Friday filer Live Oak V (NASDAQ:LOKVU), these two...
At the SPAC of Dawn Amid a restive market, SPACs have front-loaded their business this week with three of their four votes set for today and tomorrow. One of these is a completion vote, in which Bowen (NASDAQ:BOWN) will try and secure shareholder approval for its combination with Shenzhen Qianzhi BioTechnology just after having gained...
Terms Tracker for the Week Ending January 10, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. This was the first full week in January and the first non-holiday week since December 23rd. All the same, 2025 has started with a bang...